Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001104659-12-083388
Filing Date
2012-12-12
Accepted
2012-12-12 06:01:09
Documents
2
Period of Report
2012-12-04

Document Format Files

Seq Description Document Type Size
1 3 a3.html 3  
1 3 a3.xml 3 2647
2 EX-24 ex-24.htm EX-24 10950
  Complete submission text file 0001104659-12-083388.txt   14931
Mailing Address 215 FIRST STREET SUITE 440 CAMBRIDGE MA 02142
Business Address 215 FIRST STREET SUITE 440 CAMBRIDGE MA 02142 617-252-9300
Verastem, Inc. (Issuer) CIK: 0001526119 (see all company filings)

EIN.: 273269467 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 215 FIRST STREET SUITE 440 CAMBRIDGE MA 02142
Business Address
Paterson Dan (Reporting) CIK: 0001563202 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-35403 | Film No.: 121257711